Coordinated immune dysregulation in Juvenile Dermatomyositis revealed by single-cell genomics.

Autoimmune diseases Autoimmunity Bioinformatics Rheumatology

Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
14 May 2024
Historique:
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 14 5 2024
Statut: aheadofprint

Résumé

Juvenile Dermatomyositis (JDM) is one of several childhood-onset autoimmune disorders characterized by a type I interferon response and autoantibodies. Treatment options are limited due to incomplete understanding of how the disease emerges from dysregulated cell states across the immune system. We therefore investigated the blood of JDM patients at different stages of disease activity using single-cell transcriptomics paired with surface protein expression. By immunophenotyping peripheral blood mononuclear cells, we observed skewing of the B cell compartment towards an immature naive state as a hallmark of JDM at diagnosis. Furthermore, we find that these changes in B cells are paralleled by T cell signatures suggestive of Th2-mediated inflammation that persist despite disease quiescence. We applied network analysis to reveal that hyperactivation of the type I interferon response in all immune populations is coordinated with previously masked cell states including dysfunctional protein processing in CD4+ T cells and regulation of cell death programming in NK, CD8+ T cells and gdT cells. Together, these findings unveil the coordinated immune dysregulation underpinning JDM and provide insight into strategies for restoring balance in immune function.

Identifiants

pubmed: 38743491
pii: 176963
doi: 10.1172/jci.insight.176963
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Gabrielle Rabadam (G)

Department of Bioengineering & Therapeutic Sciences, UCSF, San Francisco, United States of America.

Camilla Wibrand (C)

Aarhus University, Aarhus University, Aarhus, Denmark.

Emily Flynn (E)

CoLabs, UCSF, San Francisco, United States of America.

George C Hartoularos (GC)

Graduate Program in Biological and Medical Informatics, UCSF, San Francisco, United States of America.

Yang Sun (Y)

Division of Rheumatology, UCSF, San Franscisco, United States of America.

Chioma Madubata (C)

Division of Pediatric Rheumatology, UCSF, San Franscisco, United States of America.

Gabriela K Fragiadakis (GK)

CoLabs, UCSF, San Francisco, United States of America.

Jimmie Ye (J)

Division of Pediatric Rheumatology, UCSF, San Franscisco, United States of America.

Susan Kim (S)

Division of Pediatric Rheumatology, UCSF, San Franscisco, United States of America.

Zev J Gartner (ZJ)

Department of Pharmaceutical Chemistry, UCSF, San Francisco, United States of America.

Marina Sirota (M)

Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America.

Jessica Neely (J)

Division of Pediatric Rheumatology, UCSF, San Franscisco, United States of America.

Classifications MeSH